MAIA Stock Summary and Trading Ideas (Maia Biotechnology | AMEX:MAIA)

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.

Maia Biotechnology trades on the AMEX stock market under the symbol MAIA.

As of January 17, 2025, MAIA stock price declined to $2.00 with 143,870 million shares trading.

MAIA has a market cap of $52.32 million. This is considered a Micro Cap stock.

The top ETF exchange traded funds that MAIA belongs to (by Net Assets): VTI, VXF, IWC.

MAIA has outperformed the market in the last year with a return of +35.1%, while the SPY ETF gained +28.0%. However, in the most recent history, MAIA shares have underperformed the stock market with its stock returning -20.5% in the last 3 month period and -10.3% for the last 2 week period, while SPY has returned +3.0% and +1.0%, respectively.

MAIA support price is $1.87 and resistance is $2.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MAIA shares will trade within this expected range on the day.